|
PIAS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.979800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.823200E-04 |
| Normal-vs-Stage2 |
6.774200E-01 |
| Normal-vs-Stage3 |
4.803200E-01 |
| Normal-vs-Stage4 |
6.001400E-01 |
| Stage1-vs-Stage2 |
6.970300E-02 |
| Stage1-vs-Stage3 |
1.189190E-04 |
| Stage1-vs-Stage4 |
1.061330E-03 |
| Stage2-vs-Stage3 |
3.590200E-01 |
| Stage2-vs-Stage4 |
4.343800E-01 |
| Stage3-vs-Stage4 |
9.055800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.779600E-01 |
| Normal-vs-AfricanAmerican |
5.120400E-02 |
| Normal-vs-Asian |
9.290300E-02 |
| Caucasian-vs-AfricanAmerican |
1.654190E-01 |
| Caucasian-vs-Asian |
3.912800E-01 |
| AfricanAmerican-vs-Asian |
8.966000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.469400E-01 |
| Normal-vs-Female |
9.96749999999658E-05 |
| Male-vs-Female |
2.07389999995478E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.539800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.727800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.259000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.324800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.278230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.039600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.053000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.736400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.741000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.78149999991484E-08 |
| Normal-vs-Grade 2 |
7.361800E-03 |
| Normal-vs-Grade 3 |
5.315000E-01 |
| Normal-vs-Grade 4 |
2.663800E-01 |
| Grade 1-vs-Grade 2 |
4.862800E-03 |
| Grade 1-vs-Grade 3 |
1.399140E-04 |
| Grade 1-vs-Grade 4 |
3.77760000003224E-06 |
| Grade 2-vs-Grade 3 |
2.747600E-02 |
| Grade 2-vs-Grade 4 |
1.822150E-03 |
| Grade 3-vs-Grade 4 |
1.046000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.589620E-04 |
| Normal-vs-ccB subtype |
1.168990E-01 |
| ccA subtype-vs-ccB subtype |
1.86180000305569E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.552000E-01 |
| Normal-vs-N1 |
6.608800E-01 |
| N0-vs-N1 |
4.187800E-01 |
|
|
